ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 58 filers reported holding ANNOVIS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $237,000 | – | 2,764 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 48,941 | $464,450 | 0.22% |
| Redmond Asset Management, LLC | 34,080 | $323,419 | 0.12% |
| Sterling Investment Advisors, Ltd. | 34,374 | $326,209 | 0.11% |
| Wescott Financial Advisory Group, LLC | 41,607 | $394,850 | 0.07% |
| Worth Venture Partners, LLC | 12,321 | $116,926 | 0.07% |
| Koshinski Asset Management, Inc. | 15,000 | $142,350 | 0.02% |
| Merit Financial Group, LLC | 41,200 | $390,988 | 0.01% |
| FNY Investment Advisers, LLC | 1,133 | $10 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | $2,847,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $223,964 | 0.01% |